Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PHIO

Phio Pharmaceuticals Corp

May 28 • 11:06AM ET

1.11

+0.00 0.45 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: BLRX CYCN ERNA GDTC GNTA GTBP ICU INTS RKTO TOVX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.44	Insider Own	10.62%	Shs Outstand	11.62M	Perf Week	2.31%
Market Cap	12.84M	Forward P/E	-	EPS next Y	-0.86	Insider Trans	0.82%	Shs Float	10.38M	Perf Month	-7.92%
Enterprise Value	-4.19M	PEG	-	EPS next Q	-0.34	Inst Own	5.75%	Short Float	3.19%	Perf Quarter	3.27%
Income	-10.93M	P/S	-	EPS this Y	5.17%	Inst Trans	2.84%	Short Ratio	1.39	Perf Half Y	-4.74%
Sales	0.00M	P/B	0.78	EPS next Y	37.45%	ROA	-70.87%	Short Interest	0.33M	Perf YTD	5.24%
Book/sh	1.42	P/C	0.75	EPS next 5Y	-	ROE	-76.36%	52W High	4.19 -73.63%	Perf Year	-44.75%
Cash/sh	1.47	P/FCF	-	EPS past 3/5Y	74.81% 62.91%	ROIC	-66.41%	52W Low	0.81 35.97%	Perf 3Y	-96.96%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	3.08% 4.23%	Perf 5Y	-99.54%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	77.90%	Oper. Margin	-	ATR (14)	0.05	Perf 10Y	-100.00%
Dividend Ex-Date	-	Quick Ratio	18.32	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	45.68	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	18.32	EPS Q/Q	16.09%	SMA20	-0.43%	Beta	0.82	Target Price	14.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-7.14%	Rel Volume	0.25	Prev Close	1.10
Employees	6	LT Debt/Eq	0.00	Earnings	Mar 05 AMC	SMA200	-24.98%	Avg Volume	237.85K	Price	1.11
IPO	May 10, 2012	Option/Short	No / Yes	EPS/Sales Surpr.	55.88% -	Trades		Volume	16,548	Change	0.45%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)